The Value of the Innovative Pharmaceutical Industry – A Report Summary
This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts […]
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts […]
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
Learn facts and myths about the price of medicines, healthcare cost drivers and the economic contribution of industry.
StatsCan examines the economic footprint made by Canada’s research and development pharmaceutical sector in 2018, including the contributions of Innovative Medicines Canada.
Stay informed with timely, relevant content on key issues shaping our industry.